Johnson Steven Andrew 4
4 · CORTEX PHARMACEUTICALS INC/DE/ · Filed Aug 24, 2009
Insider Transaction Report
Form 4
Johnson Steven Andrew
VP, Preclinical Development
Transactions
- Award
Options to Purchase Common Stock
2009-08-22+262,000→ 262,000 totalExercise: $0.20Exp: 2019-08-22→ Common Stock (262,000 underlying)
Footnotes (1)
- [F1]The option becomes vested and exercisable in three equal annual installments beginning on August 22, 2010.